Identification of novel interacting regions involving calcineurin and nuclear factor of activated T cells

Nuclear factor of activated T cells (NFAT) leads to the transcription of diverse inducible genes involved in many biological processes; therefore, aberrant NFAT expression is responsible for the development and exacerbation of various disorders. Since five isoforms of NFAT (NFATc1‐c4, NFAT5) exhibit distinct and overlapping functions, selective control of a part, but not all, of NFAT family members is desirable. By comparing the binding activity of each NFATc1‐c4 with its regulatory enzyme, calcineurin (CN), using a quantitative immunoprecipitation assay, we found a new CN‐binding region (CNBR) selectively functioning in NFATc1 and NFATc4. This region, termed CNBR3, is located between two preexisting CNBR1 and CNBR2, within the Ca2+ regulatory domain. The nuclear translocation of NFATc1 but not NFATc2 in T cells was suppressed by ectopic expression of CNBR3 and, accordingly, NFATc1‐dependent cytokine expression was downregulated. Through competition assays using NFATc1‐derived partial peptides and mass spectrometry with photoaffinity technology, we identified 18 amino acids in NFATc1 (Arg258 to Pro275) and 13 amino acids in CN catalytic subunit (CNA) (Asn77 to Gly89) responsible for CNA/CNBR3 binding in which Cys263 and Asp82, respectively, played crucial roles. The possible selective regulation of NFAT‐mediated biological processes by targeting this new CN/NFAT‐binding region is suggested.

[1]  Y. Nishito,et al.  Downregulation of NFAT3 Due to Lack of T-Box Transcription Factor TBX5 Is Crucial for Cytokine Expression in T Cells , 2018, The Journal of Immunology.

[2]  T. Timmusk,et al.  Regulation of different human NFAT isoforms by neuronal activity , 2016, Journal of neurochemistry.

[3]  C. Jun,et al.  Transcription factor NFAT1 controls allergic contact hypersensitivity through regulation of activation induced cell death program , 2016, Scientific Reports.

[4]  S. Reppert,et al.  NFATc1 deletion in T lymphocytes inhibits the allergic trait in a murine model of asthma , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  A. Floden,et al.  Attenuation of microglial activation in a mouse model of Alzheimer’s disease via NFAT inhibition , 2015, Journal of Neuroinflammation.

[6]  A. Vincent-Salomon,et al.  The calcineurin/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells , 2015, Cell Death and Disease.

[7]  X. Chen,et al.  Molecular and Cellular Pathobiology Nuclear Factor of Activated T-cell Activity Is Associated with Metastatic Capacity in Colon Cancer , 2014 .

[8]  R. E. Luna,et al.  The LxVP and PxIxIT NFAT motifs bind jointly to overlapping epitopes on calcineurin's catalytic domain distant to the regulatory domain. , 2014, Structure.

[9]  Xinling Liang,et al.  NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice , 2013, British journal of pharmacology.

[10]  O. Kaminuma,et al.  NFAT1 and NFAT2 Differentially Regulate IL-17A Expression in Human T Cells , 2012, International Archives of Allergy and Immunology.

[11]  Je-Min Choi,et al.  Cell permeable NFAT inhibitory peptide Sim-2-VIVIT inhibits T-cell activation and alleviates allergic airway inflammation and hyper-responsiveness. , 2012, Immunology letters.

[12]  T. Gress,et al.  Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer. , 2012, Gastroenterology.

[13]  G. A. van der Marel,et al.  Selective Modulation of Nuclear Factor of Activated T-Cell Function in Restenosis by a Potent Bipartite Peptide Inhibitor , 2012, Circulation research.

[14]  Zhaoli Chen,et al.  Expression and unique functions of four nuclear factor of activated T cells isoforms in non-small cell lung cancer , 2011, Chinese journal of cancer.

[15]  D. Auboeuf,et al.  NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene , 2010, Oncogene.

[16]  H. Abdul,et al.  Cognitive Decline in Alzheimer's Disease Is Associated with Selective Changes in Calcineurin/NFAT Signaling , 2009, The Journal of Neuroscience.

[17]  J. Redondo,et al.  A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants. , 2009, Molecular cell.

[18]  A. Miyawaki,et al.  Differential Contribution of NFATc2 and NFATc1 to TNF-α Gene Expression in T Cells1 , 2008, The Journal of Immunology.

[19]  S. Harrison,et al.  Structure of calcineurin in complex with PVIVIT peptide: portrait of a low-affinity signalling interaction. , 2007, Journal of molecular biology.

[20]  J. Redondo,et al.  Blockade of NFAT Activation by the Second Calcineurin Binding Site* , 2006, Journal of Biological Chemistry.

[21]  M. Zayzafoon Calcium/calmodulin signaling controls osteoblast growth and differentiation , 2006, Journal of cellular biochemistry.

[22]  B. Paschal,et al.  Mechanisms of Receptor‐Mediated Nuclear Import and Nuclear Export , 2005, Traffic.

[23]  P. Hogan,et al.  Structural delineation of the calcineurin-NFAT interaction and its parallels to PP1 targeting interactions. , 2004, Journal of molecular biology.

[24]  A. Rao,et al.  Activation and deactivation of gene expression by Ca2+/calcineurin-NFAT-mediated signaling. , 2004, Molecules and cells.

[25]  E. Serfling,et al.  Mice Deficient in Nuclear Factor of Activated T-Cell Transcription Factor c2 Mount Increased Th2 Responses after Infection with Nippostrongylus brasiliensis and Decreased Th1 Responses after Mycobacterial Infection , 2003, Infection and Immunity.

[26]  Lin Chen,et al.  Transcriptional regulation by calcium, calcineurin, and NFAT. , 2003, Genes & development.

[27]  N. Arai,et al.  Inhibition of NFATx Activation by an Oligopeptide: Disrupting the Interaction of NFATx with Calcineurin1 , 2001, The Journal of Immunology.

[28]  A. Rao,et al.  Partners in transcription: NFAT and AP-1 , 2001, Oncogene.

[29]  J. Redondo,et al.  Selective Inhibition of Vascular Endothelial Growth Factor–Mediated Angiogenesis by Cyclosporin a , 2001, The Journal of experimental medicine.

[30]  F. Berberich-Siebelt,et al.  The role of NF-AT transcription factors in T cell activation and differentiation. , 2000, Biochimica et biophysica acta.

[31]  J. Qin,et al.  Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. , 2000, Molecular cell.

[32]  M. Uesugi,et al.  A second calcineurin binding site on the NFAT regulatory domain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Yaffe,et al.  Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. , 1999, Science.

[34]  A. Raina,et al.  The role of cell cycle‐mediated events in Alzheimer's disease , 1999, International journal of experimental pathology.

[35]  H. Okamura,et al.  Two-site Interaction of Nuclear Factor of Activated T Cells with Activated Calcineurin* , 1998, The Journal of Biological Chemistry.

[36]  Michael J. Grusby,et al.  The transcription factor NF-ATc is essential for cardiac valve formation , 1998, Nature.

[37]  S. Harrison,et al.  Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA , 1998, Nature.

[38]  F. Alt,et al.  Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. , 1998, Immunity.

[39]  H. Fritsche,et al.  Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation , 1997, Bone Marrow Transplantation.

[40]  P. Hogan,et al.  Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.

[41]  L. Glimcher,et al.  Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. , 1996, Immunity.

[42]  D. Fruman,et al.  Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. , 1993, Current opinion in immunology.

[43]  S. R. Kushner,et al.  Amplification and purification of plasmid-encoded thioredoxin from Escherichia coli K12. , 1984, The Journal of biological chemistry.